OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09/04/2026
Voltar para busca
Dado oficial do USPTO
TRANSFUSIUS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
TRANSFUSIUS
ST13
US500000079407821Classe
5, 35, 42, 44
Pedido
79407821
Registro
7910357
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
10/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 35, 42, 44
Data de depósito
21/06/2024
Data de registro
26/08/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/08/2025
Última transação
10/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
DE
Examinador
CORWIN, KEVIN SCOTT
Unidade examinadora
M30
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Haema GmbH
Haema AG
Representantes
Deborah L. Shapiro Moses & Singer LLP
Classificação técnica
Classes Nice
Classe 5Classe 35Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Drugsin particular medicines made from blood componentsfractions and preparationswith said medicines being for the treatment of diseases and disorders of the blood; Living cells and cell fragments for medical purposesred blood cell concentrates; Living cells and cell fragments for medical purposesplatelet concentrates; Living cells for medical purposesleukocyte preparations of white bloods cells for medical purposes; blood plasmablood for medical and medical diagnostic purposes; blood cells for medical purposes; Blood componentsfractions and preparationsblood for medical purposesblood plasmablood substitutes for human use; Blood componentsfractions and preparations for injectionblood for medical purposesblood plasmablood substitutes for human use; Blood componentsfractions and preparations for automatic transplantationblood for medical purposesblood plasmablood substitutes for human use; Blood componentsfractions and preparations for transfusionblood for medical purposesblood plasmablood substitutes for human use; Blood componentsfractions and preparations for immunotherapyblood for medical purposesblood plasmablood substitutes for human use; Blood componentsfractions and preparations for autologous transfusionblood for medical purposesblood plasmablood substitutes for human use; Bloodblood fractions and blood components for medicaltherapeuticprophylactic purposesblood for medical purposesblood plasmablood substitutes for human use; Blood components for medical useblood plasmablood substitutes for human use; Blood plasma; Cells for medical useblood cell preparations; Sanitary preparations for medical purposes; Finished medical productshuman blood for medical purposes and blood plasma; Pharmaceutical preparations for the treatment of bleeding disordersheart diseasecancer; Immunotherapeutic and immunoprophylactic preparations in the nature of blood componentsfractions and preparations for immunotherapyblood for medical purposesblood plasmablood substitutes for human use; Living cells for medical purposesleukocyte preparations; Living cells and cell fragments for medical purposesplatelet and red blood cell concentratesquarantine plasmafractionated plasma; clinical medical reagents for processing human blood and blood components for use in blood transfusions and for extracorporeal blood processing stored in bagsbottlessyringes and similar containers for storing substances such as these for medical purposes; Pharmaceutical products and preparationsin particular infusion and transfusion solutions in the nature of bloodblood plasmabloods substitutes for human use and pharmaceutical preparations for the treatment of blood diseases and disorders; Pharmaceutical blood plasma preparations for the treatment of blood diseasesblood disorders; Pharmaceutical blood preparations for the treatment of blood diseasesblood disorders; Pharmaceutical blood productspharmaceuticals for the treatment of blood diseasesblood disorders; Cell material for autotransplantation and autotransfusioncells for medical use; Cell material for transplantation and transfusioncells for medical use; Cell material for medicaltherapeutic and prophylactic purposescells for medical purposes
Classe 35
Advertising services; Arranging advertising eventsorganizing events for advertising purposes; Advertising services for othersdeveloping advertising campaigns for others for attracting donors of blood and blood components; Advertising services to create brand identity for others in all mediaincluding radiotelevisioncinemaprintvideotexton-line and via teletext advertising; Promoting the goods and services of others by arranging for sponsors provide promotional sponsorships by affiliating their goods and services with sports exhibitionsart showslive music concerts
Classe 42
Technical provision and support for data processing systemsproviding technology information in the field of data processing and technical support services in the nature of troubleshooting computer software problems in connection with data processing; Providing temporary use of onlinenon-downloadable software for accessing patient treatment databases and donor databases; Providing technological and scientific information about scientific laboratory services and blood banksin particular medical research laboratories; Providing of scientific information derived from analysis of medical diagnostic results; Blood analysis services for scientific research purposes; Scientific laboratory services; Chemical laboratories and medical research laboratories; Scientific research in the field of physics; Chemistry serviceschemical analysischemical laboratories; Chemical analysis; Scientific testing servicesblood testing for scientific research purpose; Blood testing for scientific research purposeswith said testing entailing the filtrationseparation and centrifugation of blood; Laboratory trialsmedical and scientific research in the nature of conducting clinical trials for others; Development and further development of data processing computer software and hardware in the field of laboratory medicine and blood and plasma collection; Database development servicescreation of medical databases in digital form; Scientific and medical research in the medical and pharmaceutical fields; Scientific and medical research in the field of chemistry and biology; Development and establishment of testing specifications and procedures for the medical industrydevelopment of medical equipment procedures and test proceduresdonation proceduresmedical instrument procedures; Data processing servicestechnical and scientific registration and processing of patient treatment data and donor data in databases; Scientific laboratory services
Classe 44
Medical analysis services for diagnostic and treatment purposes provided by medical laboratories in connection with blood and plasma donation and clinical medical consultations in connection with the same; Pharmacy adviceproviding medical advice in the field of pharmaceuticals; providing of medical information in relation to blood donation centres; Providing of medical and pharmaceutical support via telephoneproviding medical information; Medical services featuring blood fractionation or blood transfusion for medical purposes; Medical services in the nature of blood sampling or collection; Blood examination in the nature of medical blood analysis services for diagnostic treatment purposes; medical assistance; blood bank services; Blood bank services in the nature of blood donation centres; Blood bank services in the nature of blood extraction stations; Services in the field of immunotherapymedical care; Nursing home services; Medical careimmunotherapy; Providing medical informationmedical diagnostic information through medical results; Medical careconducting medical diagnostics within the framework of conducting medical examinations; Blood bank servicesconducting of blood donationincluding platelet donationsSDR donation being erythrocytewhole blood donationplasma donationautologous donation being multiple type of cellular donations from an individual; Medical careexecution of medical and clinical examination services; nutrition consultation; Providing medical opinions in the nature of medical advice in the field of weight lossdermatologyhematology; health counseling; Medical servicestransfusion or transplantation of blood and blood components; Medical services; Rental of medical equipment; Rental of medical equipment in the nature of medical diagnostic instruments and apparatus for medical purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/04/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
23/03/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
23/03/2026
FICS
FINAL DISPOSITION NOTICE SENT TO IB
14/03/2026
FIMP
FINAL DISPOSITION PROCESSED
14/03/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
26/11/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
26/08/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
26/08/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/07/2025
PUBO
PUBLISHED FOR OPPOSITION
08/07/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/07/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/06/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/06/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/06/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/06/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
18/04/2025
RFNT
REFUSAL PROCESSED BY IB
22/02/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/02/2025
RFRR
REFUSAL PROCESSED BY MPU
04/02/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
31/12/2024
CNRT
NON-FINAL ACTION WRITTEN
30/12/2024
DOCK
ASSIGNED TO EXAMINER
21/12/2024
MAFR
APPLICATION FILING RECEIPT MAILED
28/10/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
28/10/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
24/10/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace TRANSFUSIUS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.